|
Fanghong Lu describes for SIIC the most significant aspects of his article describe para SIIC los aspectos relevantes de su artículo A long-term efficacy and safety study DIURETICS OR ARB ADDED TO CCB IN TREATMENT OF HYPERTENSION Long-term combination therapy with amlodipine plus amiloride/hydrochlorothiazide or amlodipine plus telmisartan was effective and safe for the high-risk hypertensive patients in China. The article was published by El artículo fue publicado por
Principal institution where the research took place Institución principal de la investigación 山东省医学科学院基础医学研究所, 济南市, 山东省, China  Authors' Report Crónica del Autor Bibliographic references Referencias bibliográficas ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981-97, 2002. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560-72, 2003. Dahlöf B, Sever PS, Poulter NR, et al. ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 366:895-906, 2005. Mancia G, De Backer G, Dominiczak A, et al. ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25:1751-62, 2007. Wang W, Ma L, Zhang Y, et al. The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics. J Hum Hypertens 25:271-7, 2011. Wu Y, Huxley R, Li L, et al. China NNHS Steering Committee; China NNHS Working Group. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 118:2679-86, 2008. Yang J, Lu F, Zhang C, et al. Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007. Hypertens Res 33:331-7, 2010. Other articles written by the author Fanghong Lu Otros artículos de Fanghong Lu 1. Yang J, Lu F, Zhang C et al. Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007. Hypertens Res 2010; 33:331-7. 2. 44. Zhao Y, Lu F, Sun H, Liu Z, Zhao Y, Sun S, Wang S, Diao Y, Zhang H. Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in Shandong Province of China. J Clin Hypertens (Greenwich). 2012 Sep;14(9):637-643. SIIC System of Assisted Editing (SSEA) / Sistema SIIC de Edición Asistida (SSEA)
The article is strictly related to the following sections of siicsalud El artículo se relaciona estrictamente con las siguientes secciones de siicsalud
Information about the full text Acerca del trabajo completo A 48-Week Study of Amlodipine Plus Amiloride/Hydrochlorothiazide Vs. Amlodipine Plus Telmisartan in the Treatment of Hypertension. Author / Autor Fanghong Lu1 1 Professor, 山东省医学科学院基础医学研究所, Jinan, China, Director Access to the original source International Journal of Clinical Practice Article URL: / URL del artículo: http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1742-1241 URL of Abstract page in Medline: / URL del abstract en Medline: http://www.ncbi.nlm.nih.gov/pubmed/22805271 siic DB: / siic DB: http://www.siicsalud.com/main/distriprinrel.php |
|||||||||||||||||||||||||||
Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008
